Navigation Links
MetaStat Announces Presentations at the 2012 San Antonio Breast Cancer Symposium
Date:12/4/2012

MONTCLAIR, N.J., Dec. 4, 2012 /PRNewswire/ -- MetaStat, Inc. ("MetaStat" or the "Company") (OTCBB: MTST), a life science company focused on understanding and treating systemic metastasis, today announced that John S. Condeelis, Ph.D., Chairman of MetaStat's Scientific Advisory Board, and Joan Jones, M.D., a member of MetaStat's Clinical Advisory Board, will be presenting data on the Company's licensed metastatic breast cancer markers at the CTRC-AACR 2012 San Antonio Breast Cancer Symposium on December 4-8, 2012, in San Antonio, Texas.

About MetaStat, Inc.

MetaStat was formed to help cancer patients benefit from recent discoveries in how cancer spreads through the bloodstream to other organs in the body in a process called metastasis. We believe our MetaSite Breast™ and MenaCalc™ diagnostic product lines will accurately predict the probability of cancer metastasizing. They are intended to allow clinicians to better "customize" cancer treatment decisions by positively identifying and differentiating high-risk patients who need aggressive therapy and by sparing low-risk patients from the harmful side effects and expense of chemotherapy and/or radiation therapies. Furthermore, we believe our MenaCalc™ diagnostic platform may be applicable in up to 80% of all solid epithelial cancers, including breast, prostate, lung and colorectal, which account for over 50% of all new cancer cases in the U.S. each year. As such, we believe our diagnostic products represent a significant breakthrough for cancer patients and their doctors because 90% of all solid tumor cancer deaths are due from metastasis.

Additionally, we believe our MenaBloc™ technology provides us with targets of intervention in key pathways for the development of targeted therapeutics that may preemptively reduce or eliminate metastasis in these tumor types.

Our technology platform(s) and corresponding products are the result of over 15 years
'/>"/>

SOURCE MetaStat, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
2. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
3. MetaStat, Inc. Executes Two New Licenses
4. Syndax Pharmaceuticals to Present Updated Overall Survival Data With Entinostat in Metastatic Breast Cancer at ASCO
5. Taiho Pharmaceutical Announces Start of Global Phase III Clinical Trial in Metastatic Colorectal Cancer with Novel Antitumor Agent TAS-102
6. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
7. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
8. Amgen Announces Termination Of Ganitumab Phase 3 Study For Futility In Metastatic Pancreatic Cancer
9. Nektar Announces that FDA Grants Fast Track Designation to Etirinotecan Pegol (NKTR-102) for the Treatment of Metastatic Breast Cancer
10. MetaStat Announces Stock Trading on OTC Bulletin Board
11. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014  Cannabis Science, ... cannabis formulation-based drug development and related consulting, is ... of multiple strains of cannabis and European Union ... select the best strains for development of proprietary ... cannabis formulations to market for critical ailments such ...
(Date:7/31/2014)... , July 31, 2014 genae, a ... industries, announced today the incorporation of genae UK in ... has one of the largest medical device markets in the ... it is projected to increase by a CAGR of 6.0% until ... equal to 9.5% of GDP. Despite recessionary pressures, market growth rates ...
(Date:7/31/2014)... July 31, 2014 Astellas has appointed ... corporate and employee communications in the Americas region. ... , senior vice president, chief communications officer. In ... and leading corporate brand initiatives and reputation management ... and South America . She ...
Breaking Medicine Technology:Cannabis Science Initiates Scientific Cultivation Programs to Test Multiple Strains of Cannabis to Obtain Extract Formulations for Clinical Drug Development Targeting Multiple Critical Ailments Starting with Cancer and Neurological Disorders 2genae Opens Offices in London 2Astellas Hires Industry Veteran Moyra Knight as Head of Corporate and Employee Communications 2
... 16, 2011 Reportlinker.com announces that a new ... US Medical Waste Management Industry ... This report analyzes the US market for Medical ... Segments: Management & Disposal Services, Collection Equipment, Liquid ...
... 2011 Endologix, Inc. (Nasdaq: ELGX ), ... announced the filing of its annual report on Form ... fourth quarter and full year 2010 financial results. ... to Endologix,s December 2010 acquisition of Nellix, Inc., the ...
Cached Medicine Technology:US Medical Waste Management Industry 2US Medical Waste Management Industry 3US Medical Waste Management Industry 4US Medical Waste Management Industry 5US Medical Waste Management Industry 6US Medical Waste Management Industry 7US Medical Waste Management Industry 8Endologix Files Form 10-K; Nellix Purchase Price Allocation Finalized 2Endologix Files Form 10-K; Nellix Purchase Price Allocation Finalized 3
(Date:7/31/2014)... Hook Your Ex, a system created by Steve Pratt, ... hungry for their partner, to the point of starvation, that they ... has been taught to hundreds of men and women across the ... Ex review , Shane Michaels agrees this simple trick is genius ... a second chance at getting back together with their ex. ...
(Date:7/31/2014)... United Theological Seminary is pleased to ... Donne and Peter J. Bellini. Both began their teaching ... is a Director of Non-Degree Programs, Mark Abbott, who ... Le Donne, Assistant Professor of New Testament, received a ... Testament, Second Temple Judaism, and Greek courses. His research ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Cosmetic Town ... best Plastic Surgeons to consumers considering cosmetic treatments. ... their peers whose goal is to educate prospective patients ... are selected through a validated referral system that helps ... the best in their respective fields. , Cosmetic ...
(Date:7/31/2014)... 2014 The VitaSleep FDA cleared ... and provide an easier breathing capacity by slightly adjusting ... that people can breathe easier and helps reduce or ... so that it can meet the needs of each ... often shared by actual customer reviews. Johathan R. ...
(Date:7/31/2014)... Ce-Classes.com has developed a Learning Management ... to pass inspections and audits. Ce-Classes.com can ... accreditation and state licensing criteria by providing their ... administrators can monitor employee compliance with mandatory training ... can be developed based on the policies and ...
Breaking Medicine News(10 mins):Health News:Hook Your Ex Review by Shane Michaels Exposes Steve Pratt And His New Method For Getting Back With The Ex 2Health News:Growing Seminary Welcomes New Faculty 2Health News:The New Doctors’ Directory, Cosmetic Town Does the Research for Consumers of Plastic Surgeries 2Health News:New Dental Device Reviews to Stop Snoring by VitalSleep 2Health News:Company Helps Healthcare Agencies to Pass Inspections and Audits 2Health News:Company Helps Healthcare Agencies to Pass Inspections and Audits 3
... - Certified asthma & allergy friendly(TM) by the Asthma, and Allergy ... ... to More Consumers, ENGLEWOOD CLIFFS, N.J., March 20 ... To help those suffering from,common household allergies, LG Electronics today announced ...
... Next Steps in $128 Million Contract -, GAITHERSBURG, ... today announced positive interim results from the,500-subject Phase 1/2 ... vaccine for H5N1 influenza. The trial met a key ... patch,was used with a single dose of the 45-microgram ...
... IDMI ) today reported financial results for the ... information presented,represents the consolidated results of IDM Pharma, Inc. ... the quarter ended December 31, 2007 were $5.6,million, and ... for the quarter.,Total revenues for the year ended December ...
... Nordic Naturals was,recently named the "Top-Rated ... Vitamin and Supplement Users. Receiving two recognitions, ... #1 Rated Health Food,Store Brand for Consumer ... ratings of all brands considered, throughout 8,different ...
... smokers who were treated for cerebral aneurysms,with coil ... greater risk of developing another aneurysm, say neurological ... in the first-known study of its kind. , ... of the Journal of Neurosurgery, researchers found there ...
... March 19 Patrick G. Ryan, founder,and executive chairman ... Aon effective August 1, 2008. Aon is the world,s ... human,capital consulting., Ryan commented, "The transition to a ... is complete. Aon is extremely well-positioned,for continued growth and ...
Cached Medicine News:Health News:LG Electronics Debuts Unique Allergen-Reducing Steam Washer/Dryer Combo 2Health News:LG Electronics Debuts Unique Allergen-Reducing Steam Washer/Dryer Combo 3Health News:LG Electronics Debuts Unique Allergen-Reducing Steam Washer/Dryer Combo 4Health News:Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels 2Health News:Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels 3Health News:Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels 4Health News:Study Finds Single Dose of Iomai Patch With Pandemic Flu Vaccine Achieves Protective Levels 5Health News:IDM Pharma Reports 2007 Financial Results 2Health News:IDM Pharma Reports 2007 Financial Results 3Health News:IDM Pharma Reports 2007 Financial Results 4Health News:IDM Pharma Reports 2007 Financial Results 5Health News:IDM Pharma Reports 2007 Financial Results 6Health News:IDM Pharma Reports 2007 Financial Results 7Health News:IDM Pharma Reports 2007 Financial Results 8Health News:IDM Pharma Reports 2007 Financial Results 9Health News:Nordic Naturals Named Top-Rated Supplement Brand in ConsumerLab.com Survey of Vitamin and Supplement Users! 2Health News:Smokers treated for brain aneurysm with coils at higher risk of recurrence 2Health News:Patrick G. Ryan Announces Intention to Retire from Aon 2Health News:Patrick G. Ryan Announces Intention to Retire from Aon 3
For the quantitative determination of total glucose in serum....
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L). Single vial, dry powder reagent....
Inorganic phosphorus (UV method) reagent is for the quantitative determination of inorganic phosphorus in human serum....
For the quantitative determination of Inorganic Phosphorus in serum. Linearity: 12.0 mg/dl....
Medicine Products: